161 related articles for article (PubMed ID: 33689536)
1. Survival impact of incidental subventricular zone irradiation in IDH-wildtype glioblastoma.
Hallaert G; Pinson H; Van den Broecke C; Sweldens C; Van Roost D; Kalala JP; Boterberg T
Acta Oncol; 2021 May; 60(5):613-619. PubMed ID: 33689536
[TBL] [Abstract][Full Text] [Related]
2. Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.
Chen L; Guerrero-Cazares H; Ye X; Ford E; McNutt T; Kleinberg L; Lim M; Chaichana K; Quinones-Hinojosa A; Redmond K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):616-22. PubMed ID: 23540348
[TBL] [Abstract][Full Text] [Related]
3. Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial.
Elicin O; Inac E; Uzel EK; Karacam S; Uzel OE
J Neurooncol; 2014 Jun; 118(2):413-419. PubMed ID: 24668610
[TBL] [Abstract][Full Text] [Related]
4. Impact of subventricular zone irradiation on outcome of patients with glioblastoma.
Mathew BS; Kaliyath SB; Krishnan J; Bhasi S
J Cancer Res Ther; 2018; 14(6):1202-1206. PubMed ID: 30488830
[TBL] [Abstract][Full Text] [Related]
5. Subventricular zones: new key targets for glioblastoma treatment.
Khalifa J; Tensaouti F; Lusque A; Plas B; Lotterie JA; Benouaich-Amiel A; Uro-Coste E; Lubrano V; Cohen-Jonathan Moyal E
Radiat Oncol; 2017 Apr; 12(1):67. PubMed ID: 28424082
[TBL] [Abstract][Full Text] [Related]
6. What is the role of the subventricular zone in radiotherapy of glioblastoma patients?
Bender K; Träger M; Wahner H; Onken J; Scheel M; Beck M; Ehret F; Budach V; Kaul D
Radiother Oncol; 2021 May; 158():138-145. PubMed ID: 33636228
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.
Lee P; Eppinga W; Lagerwaard F; Cloughesy T; Slotman B; Nghiemphu PL; Wang PC; Kupelian P; Agazaryan N; Demarco J; Selch MT; Steinberg M; Kang JJ
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):609-15. PubMed ID: 23462418
[TBL] [Abstract][Full Text] [Related]
8. Clinicogenetic characteristics and the effect of radiation on the neural stem cell niche in subventricular zone-contacting glioblastoma.
Kahng JY; Kang BH; Lee ST; Choi SH; Kim TM; Park CK; Won JK; Park SH; Son J; Lee JH
Radiother Oncol; 2023 Sep; 186():109800. PubMed ID: 37423479
[TBL] [Abstract][Full Text] [Related]
9. Sex-based survival differences in IDH-wildtype glioblastoma: Results from a retrospective cohort study.
Hallaert G; Pinson H; Van den Broecke C; Van Roost D; Kalala JP; Boterberg T
J Clin Neurosci; 2021 Sep; 91():209-213. PubMed ID: 34373029
[TBL] [Abstract][Full Text] [Related]
10. Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.
Berger K; Turowski B; Felsberg J; Malzkorn B; Reifenberger G; Steiger HJ; Budach W; Haussmann J; Knipps J; Rapp M; Hänggi D; Sabel M; Mijderwijk HJ; Kamp MA
J Cancer Res Clin Oncol; 2021 Jan; 147(1):253-262. PubMed ID: 32748120
[TBL] [Abstract][Full Text] [Related]
11. MR Imaging, MGMT Promoter Methylation Features and Prognostic Analysis of Subventricular Zone Contacting IDH Wild-type Glioblastoma.
Liu R; Liu Q; Zhao K; Liu M; Sun G; Xu B
Curr Med Imaging; 2023; 19(12):1378-1386. PubMed ID: 36694322
[TBL] [Abstract][Full Text] [Related]
12. Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide.
Foro Arnalot P; Pera O; Rodriguez N; Sanz X; Reig A; Membrive I; Ortiz A; Granados R; Algara M
Clin Transl Oncol; 2017 Oct; 19(10):1225-1231. PubMed ID: 28389881
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of MGMT promoter methylation on the survival of TMZ treated
Chai R; Li G; Liu Y; Zhang K; Zhao Z; Wu F; Chang Y; Pang B; Li J; Li Y; Jiang T; Wang Y
Cancer Biol Med; 2021 Feb; 18(1):272-282. PubMed ID: 33628600
[TBL] [Abstract][Full Text] [Related]
14. Subventricular zone contacting glioblastoma: tumor size, molecular biological factors and patient survival.
Hallaert G; Pinson H; Van den Broecke C; Vanhauwaert D; Van Roost D; Boterberg T; Kalala JP
Acta Oncol; 2020 Dec; 59(12):1474-1479. PubMed ID: 32672481
[TBL] [Abstract][Full Text] [Related]
15. Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.
Saito T; Muragaki Y; Maruyama T; Komori T; Nitta M; Tsuzuki S; Fukui A; Kawamata T
Neurosurg Rev; 2020 Dec; 43(6):1583-1593. PubMed ID: 31705405
[TBL] [Abstract][Full Text] [Related]
16. Subventricular zone volumetric and dosimetric changes during postoperative brain tumor irradiation and its impact on overall survival.
Darázs B; Ruskó L; Végváry Z; Ferenczi L; Dobi Á; Paczona V; Varga Z; Fodor E; Hideghéty K
Phys Med; 2019 Dec; 68():35-40. PubMed ID: 31733404
[TBL] [Abstract][Full Text] [Related]
17. Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns.
Comas S; Luguera E; Molero J; Balaña C; Estival A; Castañer S; Carrato C; Hostalot C; Teixidor P; Villà S
Clin Transl Oncol; 2021 Mar; 23(3):554-564. PubMed ID: 32728970
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
19. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.
Li H; Li J; Cheng G; Zhang J; Li X
Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705
[TBL] [Abstract][Full Text] [Related]
20. Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide.
Gomes I; Moreno DA; Dos Reis MB; da Silva LS; Leal LF; Gonçalves GM; Pereira CA; Oliveira MA; de Medeiros Matsushita M; Reis RM
J Neurooncol; 2021 Jan; 151(2):135-144. PubMed ID: 33400009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
